These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15388990)

  • 21. A mutation (N177S) in the structurally conserved helix initiation peptide motif of keratin 5 causes a mild EBS phenotype.
    Liovic M; Bowden PE; Marks R; Komel R
    Exp Dermatol; 2004 May; 13(5):332-4. PubMed ID: 15140024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic disorders of keratin: are scarring alopecias a sub-set?
    Rothnagel JA; Longley MA; Holder RA; Bundman DS; Seki T; Bickenbach JR; Roop DR
    J Dermatol Sci; 1994 Jul; 7 Suppl():S164-9. PubMed ID: 7528048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The keratins and their disorders.
    Rugg EL; Leigh IM
    Am J Med Genet C Semin Med Genet; 2004 Nov; 131C(1):4-11. PubMed ID: 15452838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel and recurrent mutations in keratin KRT5 and KRT14 genes in epidermolysis bullosa simplex: implications for disease phenotype and keratin filament assembly.
    Müller FB; Küster W; Wodecki K; Almeida H; Bruckner-Tuderman L; Krieg T; Korge BP; Arin MJ
    Hum Mutat; 2006 Jul; 27(7):719-20. PubMed ID: 16786515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermolysis bullosa simplex.
    Sprecher E
    Dermatol Clin; 2010 Jan; 28(1):23-32. PubMed ID: 19945613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic bases of epidermolysis bullosa simplex and epidermolytic hyperkeratosis.
    Fuchs E; Coulombe P; Cheng J; Chan YM; Hutton E; Syder A; Degenstein L; Yu QC; Letai A; Vassar R
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):25S-30S. PubMed ID: 7525738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Drosophila Model of Epidermolysis Bullosa Simplex.
    Bohnekamp J; Cryderman DE; Paululat A; Baccam GC; Wallrath LL; Magin TM
    J Invest Dermatol; 2015 Aug; 135(8):2031-2039. PubMed ID: 25830653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in the rod domain of keratin 2e in patients with ichthyosis bullosa of Siemens.
    Rothnagel JA; Traupe H; Wojcik S; Huber M; Hohl D; Pittelkow MR; Saeki H; Ishibashi Y; Roop DR
    Nat Genet; 1994 Aug; 7(4):485-90. PubMed ID: 7524919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermolysis bullosa simplex in Israel: clinical and genetic features.
    Ciubotaru D; Bergman R; Baty D; Indelman M; Pfendner E; Petronius D; Moualem H; Kanaan M; Ben Amitai D; McLean WH; Uitto J; Sprecher E
    Arch Dermatol; 2003 Apr; 139(4):498-505. PubMed ID: 12707098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How do keratinizing disorders and blistering disorders overlap?
    Hamada T; Tsuruta D; Fukuda S; Ishii N; Teye K; Numata S; Dainichi T; Karashima T; Ohata C; Furumura M; Hashimoto T
    Exp Dermatol; 2013 Feb; 22(2):83-7. PubMed ID: 23039137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel keratin 5 and 14 gene mutations in patients with epidermolysis bullosa simplex from Poland.
    Hamada T; Kawano Y; Szczecinska W; Wozniak K; Yasumoto S; Kowalewski C; Hashimoto T
    Arch Dermatol Res; 2005 Jun; 296(12):577-9. PubMed ID: 15827748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A mouse keratin 1 mutation causes dark skin and epidermolytic hyperkeratosis.
    McGowan KA; Aradhya S; Fuchs H; de Angelis MH; Barsh GS
    J Invest Dermatol; 2006 May; 126(5):1013-6. PubMed ID: 16528356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermolysis bullosa simplex with muscular dystrophy.
    Chiavérini C; Charlesworth A; Meneguzzi G; Lacour JP; Ortonne JP
    Dermatol Clin; 2010 Apr; 28(2):245-55, viii. PubMed ID: 20447487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of immortalized human epidermolysis bullosa simplex (KRT5) cell lines: trimethylamine N-oxide protects the keratin cytoskeleton against disruptive stress condition.
    Chamcheu JC; Lorié EP; Akgul B; Bannbers E; Virtanen M; Gammon L; Moustakas A; Navsaria H; Vahlquist A; Törmä H
    J Dermatol Sci; 2009 Mar; 53(3):198-206. PubMed ID: 19157792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Keratins and skin disorders.
    Lane EB; McLean WH
    J Pathol; 2004 Nov; 204(4):355-66. PubMed ID: 15495218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A keratin K10 gene mutation in a Japanese patient with epidermolytic hyperkeratosis.
    Nomura K; Meng X; Umeki K; Tamai K; Sawamura D; Hashimoto I; Kikuchi T
    Jpn J Hum Genet; 1997 Mar; 42(1):217-23. PubMed ID: 9184002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A transgenic mouse model with an inducible skin blistering disease phenotype.
    Takahashi K; Coulombe PA
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14776-81. PubMed ID: 8962131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgenic models of skin diseases.
    Rothnagel JA; Greenhalgh DA; Wang XJ; Sellheyer K; Bickenbach JR; Dominey AM; Roop DR
    Arch Dermatol; 1993 Nov; 129(11):1430-6. PubMed ID: 7694550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermolytic hyperkeratosis.
    Bale SJ; Compton JG; DiGiovanna JJ
    Semin Dermatol; 1993 Sep; 12(3):202-9. PubMed ID: 7692917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro characteristics of early epidermal progenitors isolated from keratin 14 (K14)-deficient mice: insights into the role of keratin 17 in mouse keratinocytes.
    Troy TC; Turksen K
    J Cell Physiol; 1999 Sep; 180(3):409-21. PubMed ID: 10430181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.